Beta Bionics (BBNX) Net Cash Flow (2024 - 2026)

Beta Bionics has disclosed Net Cash Flow across 3 years of filings, most recently posting $14.1 million for Q2 2026.

• In Q2 2026, Net Cash Flow rose 291.25% year-over-year to $14.1 million; the TTM figure through Jun 2026 stood at $9.2 million (down 58.08% YoY), while the FY2025 annual figure was $1.1 million, down 70.41% from the prior year.
• Net Cash Flow came in at $14.1 million for Q2 2026 at Beta Bionics, up from -$1.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $14.1 million in Q2 2026 to a low of -$9.0 million in Q2 2024.
• Average Net Cash Flow over 3 years is $1.8 million, with a median of $1.0 million recorded in 2025.
• The largest YoY upside for Net Cash Flow was 367.51% in 2025 against a maximum downside of 153.35% in 2025.
• Over 3 years, Net Cash Flow stood at $13.0 million in 2024, then plunged by 153.35% to -$6.9 million in 2025, then soared by 304.26% to $14.1 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $14.1 million in Q2 2026, -$1.4 million in Q1 2026, and -$6.9 million in Q4 2025.